Get the Stockscreener App
7.425
0.07%
-0.015
Day One Biopharmaceuticals Inc stock is traded at $7.425, with a volume of 303.81K.
It is down -0.07% in the last 24 hours and down -6.48% over the past month.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
See More
Previous Close:
$7.44
Open:
$7.36
24h Volume:
303.81K
Relative Volume:
0.20
Market Cap:
$760.56M
Revenue:
$187.64M
Net Income/Loss:
$-95.00M
P/E Ratio:
-7.8158
EPS:
-0.95
Net Cash Flow:
$-69.02M
1W Performance:
-0.87%
1M Performance:
-6.48%
6M Performance:
-6.24%
1Y Performance:
-49.25%
1-Day Range:
$7.36
$7.62
1-Week Range:
$6.90
$7.62
52-Week Range:
$5.635
$16.76
Day One Biopharmaceuticals Inc Stock (DAWN) Company Profile
Name
Day One Biopharmaceuticals Inc
Sector
Industry
Phone
650 484-0899
Address
2000 SIERRA POINT PARKWAY, SUITE 501, BRISBANE
Compare DAWN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DAWN
Day One Biopharmaceuticals Inc
|
7.425 | 762.09M | 187.64M | -95.00M | -69.02M | -0.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.97 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
632.67 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
435.39 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.90 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
181.94 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Day One Biopharmaceuticals Inc Stock (DAWN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-19-25 | Initiated | Piper Sandler | Overweight |
| Oct-09-24 | Reiterated | Needham | Buy |
| Aug-01-24 | Upgrade | BofA Securities | Underperform → Buy |
| Apr-24-24 | Reiterated | Needham | Buy |
| Apr-25-23 | Downgrade | BofA Securities | Buy → Underperform |
| Feb-08-23 | Initiated | CapitalOne | Overweight |
| Feb-03-23 | Initiated | Oppenheimer | Perform |
| Dec-15-22 | Initiated | H.C. Wainwright | Buy |
| Dec-14-22 | Initiated | Needham | Buy |
| Dec-05-22 | Initiated | Goldman | Buy |
| Dec-01-22 | Initiated | BofA Securities | Buy |
View All
Day One Biopharmaceuticals Inc Stock (DAWN) Latest News
Will Day One Biopharmaceuticals Inc. stock maintain growth storyJuly 2025 Snapshot & AI Enhanced Market Trend Forecasts - newser.com
What Wall Street predicts for Day One Biopharmaceuticals Inc. stock priceJuly 2025 Summary & Technical Pattern Based Buy Signals - newser.com
How Day One Biopharmaceuticals Inc. stock benefits from global expansionForecast Cut & Advanced Technical Analysis Signals - newser.com
Will Day One Biopharmaceuticals Inc. price bounce be sustainableEarnings Overview Report & Community Consensus Stock Picks - newser.com
Will Day One Biopharmaceuticals Inc. stock remain a Wall Street favoritePortfolio Value Summary & Stepwise Trade Execution Plans - newser.com
Key resistance and support levels for Day One Biopharmaceuticals Inc.Quarterly Growth Report & Daily Oversold Stock Bounce Ideas - newser.com
Will Day One Biopharmaceuticals Inc. stock recover faster than peersWeekly Investment Summary & Daily Volume Surge Trade Alerts - newser.com
Y Intercept Hong Kong Ltd Invests $1.83 Million in Day One Biopharmaceuticals, Inc. $DAWN - MarketBeat
Pattern recognition hints at Day One Biopharmaceuticals Inc. upsideTrade Analysis Report & Weekly Momentum Picks - newser.com
What Fibonacci levels say about Day One Biopharmaceuticals Inc. reboundJuly 2025 Price Swings & Verified Stock Trade Ideas - newser.com
Applying Wyckoff theory to Day One Biopharmaceuticals Inc. stockJuly 2025 Retail & Capital Efficiency Focused Ideas - newser.com
Day One Biopharmaceuticals Inc expected to post a loss of 29 cents a shareEarnings Preview - TradingView
Day One Biopharmaceuticals (NASDAQ:DAWN) Given "Sell (D-)" Rating at Weiss Ratings - MarketBeat
Day One Biopharmaceuticals Inc. stock outlook for YEARJuly 2025 Price Swings & Advanced Technical Analysis Signals - newser.com
Why Day One Biopharmaceuticals Inc. stock attracts global investors2025 Macro Impact & Step-by-Step Trade Execution Guides - newser.com
What does recent volatility data suggest for Day One Biopharmaceuticals Inc.Volume Spike & Verified Chart Pattern Signals - newser.com
Forecasting Day One Biopharmaceuticals Inc. price range with options data2025 Volatility Report & Weekly Top Gainers Trade List - newser.com
Market reaction to Day One Biopharmaceuticals Inc.’s recent news2025 Institutional Moves & Weekly Breakout Stock Alerts - newser.com
Multi factor analysis applied to Day One Biopharmaceuticals Inc.2025 Big Picture & Safe Entry Momentum Tips - newser.com
Wall Street Analysts See a 234.66% Upside in Day One Biopharmaceuticals (DAWN): Can the Stock Really Move This High? - sharewise.com
Day One Biopharmaceuticals Advances Cancer Treatment with DAY301 Study - MSN
Can Day One Biopharmaceuticals Inc. rally from current levels2025 Historical Comparison & Accurate Intraday Trade Tips - newser.com
Day One Biopharmaceuticals Inc Stock (DAWN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.68%
0.96%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):